HMG-CoA Reductase Inhibitor

DRUG3 trials

Sponsors

Hiroshima liver study group, Seoul National University Hospital, Universiti Sains Malaysia

Conditions

Chronic hepatitis CEndothelial DysfunctionHyperlipidemias

Phase 4

Effect of Probucol and/or Cilostazol on Mean IMT in Patients With Coronary Heart dIsease

CompletedNCT01291641

Seoul National University HospitalHyperlipidemias

Start: 2011-03-31End: 2017-03-31Updated: 2019-09-20

Unknown Phase

Efficacy of PEG-IFN alfa-2b plus Ribabirin and HMG-CoA reductase inhibitor combination antiviral therapy ; pilot study

Active, not recruitingJPRN-UMIN000000713

Hiroshima liver study groupChronic hepatitis C

Start: 2006-12-01Target: 10Updated: 2025-07-18

Endothelial Microparticles as Potential Biomarkers of Endothelial Dysfunction

CompletedNCT04512404

Universiti Sains MalaysiaEndothelial Dysfunction

Start: 2016-10-13End: 2022-05-01Updated: 2022-11-08